TY  - GEN
AU  - Pascale,Alina
AU  - Serfaty,Lawrence
TI  - Triple therapy with first generation HCV protease inhibitors: lead-in or no lead-in phase?
SN  - 1600-0641
PY  - 2013///0723
KW  - Antiviral Agents
KW  - administration & dosage
KW  - Cost-Benefit Analysis
KW  - Dose-Response Relationship, Drug
KW  - Drug Administration Schedule
KW  - Drug Therapy, Combination
KW  - Genotype
KW  - Hepacivirus
KW  - enzymology
KW  - Hepatitis C
KW  - drug therapy
KW  - Humans
KW  - Interferon-alpha
KW  - Oligopeptides
KW  - Polyethylene Glycols
KW  - Proline
KW  - Protease Inhibitors
KW  - Recombinant Proteins
KW  - Ribavirin
KW  - Treatment Outcome
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1016/j.jhep.2012.09.023
ER  -